Abstract

Background and ImportanceELISA is the most commonly used technique to determine adalimumab (ADL) levels in patients with inflammatory bowel disease (IBD), as it is simple and inexpensive. Its disadvantage is...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call